Ashok Palaniappan

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Technology in cancer research & treatment

PeerJ

BMC cancer

PloS one

SASTRA University

University of Illinois at Urbana-Champaign (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

SASTRA University Jun 10 2017

India

Sr Asst. Professor :: School of Chemical and Biotechnology

Sri Venkateswara College of Engineering Jul 01 2016 - May 20 2017

India

Assistant Professor :: Biotechnology

Chettinad Hospital and Research Institute - Jun 30 2016

India

Assistant Professor :: Computational Biology

Annamalai University Rajah Muthaiah Medical College

India

Clinical Research Associate :: Computational Biology

University of Illinois at Urbana-Champaign Aug 05 2002 - Dec 21 2005

United States

Research Assistant :: Beckman Institute for Advanced Science and Technology

University of Illinois at Urbana-Champaign Aug 21 2000 - Jul 20 2002

United States

Teaching Assistant :: Biophysics and Computational Biology

Education History

University of Illinois at Urbana-Champaign Aug 01 1999 - Dec 31 2005

United States

PHD :: Center for Biophysics and Computational Biology

Publications

Alex Stanley Balraj, Sangeetha Muthamilselvan, Rachanaa Raja, Ashok Palaniappan
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. Technology in cancer research & treatment 23 (2024)
Alex Stanley Balraj, Sangeetha Muthamilselvan, Rachanaa Raja, Ashok Palaniappan
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. Technology in cancer research & treatment 23 (2024)
Alex Stanley Balraj, Sangeetha Muthamilselvan, Rachanaa Raja, Ashok Palaniappan
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. Technology in cancer research & treatment 23 (2024)
Alex Stanley Balraj, Sangeetha Muthamilselvan, Rachanaa Raja, Ashok Palaniappan
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. Technology in cancer research & treatment 23 (2024)
Alex Stanley Balraj, Sangeetha Muthamilselvan, Rachanaa Raja, Ashok Palaniappan
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. Technology in cancer research & treatment 23 (2024)
Sangeetha Muthamilselvan, Priyannth Ramasami Sundhar Baabu, Ashok Palaniappan
Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis. Technology in cancer research & treatment 22 (2023)
Sangeetha Muthamilselvan, Priyannth Ramasami Sundhar Baabu, Ashok Palaniappan
Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis. Technology in cancer research & treatment 22 (2023)
Sangeetha Muthamilselvan, Abirami Raghavendran, Ashok Palaniappan
Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression. PloS one 17 (2) (2022)
Nilesh Anantha Subramanian, Ashok Palaniappan
NanoTox: Development of a Parsimonious In Silico Model for Toxicity Assessment of Metal-Oxide Nanoparticles Using Physicochemical Features. ACS omega 6 (17) (2021)
Arjun Sarathi, Ashok Palaniappan
Novel significant stage-specific differentially expressed genes in hepatocellular carcinoma. BMC cancer 19 (1) (2019)
Ramit Bharanikumar, Keshav Aditya R Premkumar, Ashok Palaniappan
PromoterPredict: sequence-based modelling of Escherichia coli σ70 promoter strength yields logarithmic dependence between promoter strength and sequence. PeerJ 6 (2018)

Ashok Palaniappan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ashok Palaniappan